Presentations from School leadership and program faculty help set expectations for Doctor of Pharmacy (PharmD) and graduate students during this unprecedented time.

Presentations from academic institutions and health care systems across the United States shared best practices and strategies to support the continued advancement of patient-centered outcomes research.

Experts in geriatric pharmacotherapy and substance use research explore current methods for managing chronic pain in older adults, including potential areas of improvement in patient care and policy.

Independent group will evaluate costs for certain new and existing medications and make recommendations about how to curb high drug prices.

Study co-authored by Dr. Zafar Zafari finds housing vouchers restricted to use in low-poverty neighborhoods cost less than traditional vouchers and help improve recipients’ health and life expectancy.

Family, friends, and colleagues come together to celebrate the 42-year career of Dr. Robert Beardsley.

Office manager rose to the challenge after severe storm flooded School of Pharmacy department’s floor at the Saratoga Building.

Special ceremony recognizes four graduate students in the PhD in Pharmaceutical Health Services Research program with awards celebrating superior scholastic achievement.

Collaboration between the Schools of Pharmacy and Medicine aims to develop strategies other investigators can use to help recruit and retain older adults and diverse populations in research.

Well-loved at the School of Pharmacy and the Francis King Carey School of Law, veteran professor is extolled as “an extraordinary teacher and an incredible asset” to UMB.

Fun, informative activities help familiarize new Doctor of Pharmacy (PharmD) and graduate students with the School and campus community, as well as set expectations for the year ahead.

Research team led by Dr. Linda Wastila aims to understand how a nationwide effort to reduce the use of antipsychotic medications in long-term care facilities has impacted those facilities’ use of other medications and patient health outcomes.